Although there are a number of injectable biomaterials currently under development, they present some drawbackssuch as being based on synthetic polymers, needing toxic or aggressive synthesis procedures or using raw materialswith low availability and/or high production costs. Having this in mind, a novel injectable biomaterial usingchitooligosaccharides as starting materials was developed. This system uses a widely available and cheap polymerfrom marine biomass (chitosan), which can be turned into an injectable material by water-based and ecologicallyfriendly reactions. Chitooligosaccharides were functionalized with methacrylic groups, to allow in situ crosslinking.The degree of substitution, as determined by 1H NMR, varied between 5 and 50%. The system wascharacterized in terms of kinetics of gel formation, rheology, degradation behavior and in vitro cytotoxicity. Thegelation time could be easily tailored between 1.5 and 60 min by changing the conditions of the methacrylationreaction, and the final gel presented rheological properties typical of strong gels, that is, shear stresses in the kParange. The cross-linked gel was degradable and nontoxic, presenting indeed an interesting cytokinetic effect.Injectable materials based on chitooligosaccharides are, therefore, an innovative system combining adequatebiological performance, ease of preparation, and an ecologically friendly concept of production.
展开▼
机译:尽管目前正在开发许多可注射的生物材料,但它们存在一些缺点,例如基于合成聚合物,需要有毒或侵蚀性的合成程序或使用可用性低和/或生产成本高的原材料。考虑到这一点,开发了一种以壳寡糖为原料的新型可注射生物材料。该系统使用来自海洋生物质(壳聚糖)的广泛使用的廉价聚合物,可以通过水基和生态友好的反应将其转变为可注射的材料。将壳寡糖用甲基丙烯酸基团官能化以实现原位交联。通过1 H NMR测定的取代度在5%至50%之间变化。该系统的特征在于形成凝胶的动力学,流变学,降解行为和体外细胞毒性。通过改变甲基丙烯酸化反应的条件,可以轻松地在1.5至60分钟之间调整胶凝时间,最终的胶体表现出强胶体的典型流变特性,即在kParange中的剪切应力。交联的凝胶可降解且无毒,确实具有令人感兴趣的细胞动力学作用。因此,基于壳寡糖的可注射材料是一种创新的系统,结合了充分的生物学性能,易于制备和生态友好的生产理念。
展开▼